earnings
confidence high
sentiment positive
materiality 0.75
Fulgent Genetics Q3 revenue $84.1M (+17% YoY), raises FY guidance, non-GAAP EPS $0.14
Fulgent Genetics, Inc.
- Revenue $84.1M, up 17% YoY; raised full-year 2025 revenue guidance to $325.0M.
- GAAP net loss $6.6M ($0.21/share); non-GAAP net income $4.5M ($0.14/share).
- Full-year EPS guidance raised: GAAP loss ~($1.70)/share, non-GAAP income $0.30/share.
- Adjusted EBITDA $0.7M; GAAP gross margin 42.2%, non-GAAP 44.3%.
- Cash and short-term investments $787.7M at quarter end.